1
|
Tp Dinh H, Nguyen VH, Tm Nguyen D, Nguyen MT, Kato Y. Primary Malignant Peripheral Nerve Sheath Tumor of the Cauda Equina: A Case Report and Literature Review. Cureus 2025; 17:e77096. [PMID: 39917125 PMCID: PMC11802189 DOI: 10.7759/cureus.77096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/07/2025] [Indexed: 02/09/2025] Open
Abstract
Primary malignant peripheral nerve sheath tumors (MPNSTs) arising within the cauda equina are exceptionally rare, with only 24 cases documented in English-language literature. Due to its infrequency and aggressive behavior, no standardized treatment approach has been established. This report presents a case of primary MPNST of the cauda equina, accompanied by a comprehensive literature review, aiming to elucidate the management strategies and prognosis of this uncommon yet highly malignant tumor. A 62-year-old male was diagnosed with primary intradural MPNST and underwent gross total resection (GTR) with laminectomy along with adjunctive high-energy radiotherapy. Concurrently, we analyze existing literature concerning intradural MPNSTs. Surgical resection remains the mainstay of MPNST management, although its efficacy is limited by high recurrence rates. Despite aggressive treatment modalities, including radiotherapy and chemotherapy, primary intradural MPNSTs exhibit a propensity for leptomeningeal and systemic dissemination, contributing to a dismal overall prognosis. Notably, outcomes appear to be graver compared to MPNSTs in other anatomical locations. Primary intradural MPNSTs represent a rare and formidable clinical challenge characterized by poor prognostic outcomes. While surgical excision supplemented by adjuvant radiotherapy may offer some benefit, the need for effective targeted therapies associated with neurofibromatosis type 1 (NF1) needs to be studied more to delineate optimal treatment strategies and improve patient outcomes.
Collapse
Affiliation(s)
- Hoai Tp Dinh
- Department of Neurosurgery, Hue University of Medicine and Pharmacy, Hue University, Hue, VNM
- Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, JPN
| | - Vu H Nguyen
- Department of Neurosurgery, Hue University of Medicine and Pharmacy, Hue University, Hue, VNM
| | - Dung Tm Nguyen
- Department of Neurosurgery, Hue University of Medicine and Pharmacy, Hue University, Hue, VNM
| | - Minh T Nguyen
- Department of Neurosurgery, Hue University of Medicine and Pharmacy, Hue University, Hue, VNM
| | - Yoko Kato
- Department of Neurosurgery, Fujita Health University, Toyoake, JPN
| |
Collapse
|
2
|
Cao Y, Wang YB, Bai Y, Tan XY, Ma CY, Chen Y, Yu HQ, Xu HY, Zhao G. Epidemiology, Characteristic, and Prognostic Factors of Primary Sporadic Intradural Malignant Peripheral Nerve Sheath Tumor in the Spinal Canal: A Systematic Literature Review. Front Oncol 2022; 12:911043. [PMID: 35898898 PMCID: PMC9309257 DOI: 10.3389/fonc.2022.911043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2022] [Accepted: 06/13/2022] [Indexed: 11/23/2022] Open
Abstract
Purpose Primary sporadic intradural malignant peripheral nerve sheath tumor (MPNST) in the spinal canal is a type of rare neoplasm with challenging diagnosis and therapy. The overall prognosis of this tumor is markedly different from that of the usual spinal intradural tumors. The purpose of this systematic review is to reduce the misdiagnosis and enhance the prognosis of the disease by reviewing the literature. Methods PubMed, Medline, and Embase databases were searched for articles in English language published from 1980 to May 2021, yielding 500 potentially relevant articles. The keywords were as follows: “spinal”, “malignant peripheral nerve sheath tumor”, “neurosarcoma”, “malignant schwannoma”, and “malignant neurofibroma”. Thirteen papers met the eligibility criteria, including 55 cases with spinal intradural primary sporadic MPNSTs, which were confirmed by post-operation pathology. We further analyzed the clinical manifestations, radiological manifestations, pathological features, comprehensive treatment strategies, and prognosis. Results Fifty-five spinal intradural primary sporadic MPNSTs from 30 (54.5%) male and 25 (45.5%) female patients with an average age at diagnosis of 40 years (range, 3–70 years) were included in the study. The most common clinical manifestations were local or radicular pain and motor disturbance. All tumors had significant enhancement and heterogeneous enhancement was more common. Out of 18 lesions, 14 were diagnosed as high grade and the remaining 4 were diagnosed as low grade. The ki-67 labeling index ranged from 5% to 60%. The median recurrence and survival time were 36 and 72 months, respectively. The log-rank tests indicated that significant predictors of OS were patient age (≤30 vs. >30 years) at the time of diagnosis and the presence of metastatic disease, and similar analyses for RFS demonstrated that the presence of metastatic disease was the only significant predictor (60 vs. 10 months). The multivariate Cox proportional hazards regression analysis revealed that absence of metastasis was an independent factor for predicting a favorable prognosis. Conclusions Spinal intradural primary sporadic MPNSTs are challenging malignant tumors without a systematic treatment plan. The factors affecting its prognosis are not clear. Even after surgical treatment and adjuvant treatment, the recurrence rate and mortality rate are still high. Clinicians should be alert to the possibility of this disease and achieve early detection and treatment.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | - Gang Zhao
- *Correspondence: Hai-Yang Xu, ; Gang Zhao,
| |
Collapse
|
3
|
Bachmann N, Leiser D, Pica A, Bachtiary B, Weber DC. Clinical Outcome After Pencil Beam Scanning Proton Therapy of Patients With Non-Metastatic Malignant and Benign Peripheral Nerve Sheath Tumors. Front Oncol 2022; 12:881665. [PMID: 35832560 PMCID: PMC9271998 DOI: 10.3389/fonc.2022.881665] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2022] [Accepted: 05/20/2022] [Indexed: 11/13/2022] Open
Abstract
ObjectivePeripheral nerve sheath tumors (PNSTs) commonly arise from peripheral nerve roots and grow locally invasive. Malignant PNSTs (mPNSTs) represent aggressive sarcomas of neural origin that can originate from PNSTs. Radiation therapy is commonly used as part of the required multimodal treatment. However, both entities tend to occur early in life and are associated with the genetic disorder neurofibromatosis type 1 (NF-1), which is known to cause increased radiosensitivity. Pencil beam scanning proton therapy (PBSPT) allows for a minimization of the dose delivered to organs at risk and the integral dose and, thus, potentially also a reduction of radiation-induced adverse events. We report the clinical outcome and toxicity rates of patients with (m)PNSTs treated with PBSPT.MethodsWe retrospectively reviewed 36 patients who received PBSPT (median dose, 64 GyRBE) with curative intent for (m)PNSTs between 1999 and 2020 at our institute. Twenty-eight (78%) and 8 (22%) patients were treated at diagnosis and for tumor recurrence/progression, respectively. The median age was 32 years (range, 3–75), and 25 (69%) patients were male. mPNST and PNST were diagnosed in 31 (86%) and 5 (14%) patients, respectively. Underlying NF-1 disease was found in 8 (22%) patients. Acute and late toxicities were recorded according to Common Terminology Criteria for Adverse Events, version 4.1 (CTCAE v4.1). Overall survival (OS), local control (LC), and distant control (DC) were estimated using the Kaplan–Meier method.ResultsWith a median follow-up time of 31 months (range, 4–194), 13 (36%) patients died from a progressive disease, 8 (22%) experienced local failure, and 14 (39%) experienced distant failure after PBSPT. Estimated 2-year OS, LC, and DC were 75.5%, 73.5%, and 61.2%, respectively. Acute grade 3 toxicity (dermatitis, mucositis, and pain) was observed in 5 (14%) patients. Late grade 3 cataract and osteonecrosis were both observed in 1 (3%) patient at 34 and 194 months after PBSPT, respectively. There was no late grade >3 toxicity or radiation-induced secondary cancer.ConclusionTo our knowledge, this is the first study to analyze the outcome of (m)PNSTs treated with proton therapy using a PBS delivery paradigm. In our cohort, consisting mainly of patients with mPNSTs, we report reasonable oncological outcomes and low toxicity rates after PBSPT.
Collapse
Affiliation(s)
- Nicolas Bachmann
- Center for Proton Therapy, Paul Scherrer Institute, ETH Domain, Villigen, Switzerland
- Department of Radiation Oncology, Inselspital, Bern University Hospital, Bern, Switzerland
| | - Dominic Leiser
- Center for Proton Therapy, Paul Scherrer Institute, ETH Domain, Villigen, Switzerland
| | - Alessia Pica
- Center for Proton Therapy, Paul Scherrer Institute, ETH Domain, Villigen, Switzerland
| | - Barbara Bachtiary
- Center for Proton Therapy, Paul Scherrer Institute, ETH Domain, Villigen, Switzerland
| | - Damien C. Weber
- Center for Proton Therapy, Paul Scherrer Institute, ETH Domain, Villigen, Switzerland
- Department of Radiation Oncology, Inselspital, Bern University Hospital, Bern, Switzerland
- Department of Radiation Oncology, University Hospital of Zürich, Zürich, Switzerland
- *Correspondence: Damien C. Weber, ;
| |
Collapse
|
4
|
Liu J, Gao C, Fu H, Zhou X, Zhang L, Tang X, Wu Y, Zhu H, Yang S, Qu Y, Yang Y, Yang H. Implementation of multi-mode nursing insulation program for patients receiving surgery for spine tumor: a propensity score-matched analysis. BMC Surg 2022; 22:8. [PMID: 34996399 PMCID: PMC8742400 DOI: 10.1186/s12893-021-01463-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2021] [Accepted: 12/30/2021] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Spinal tumor surgery usually involved long operation time, large area of soft tissue resection and long wound, and was prone to hypothermia during the operation. Therefore, actively promoting insulation and optimizing the intraoperative insulation program have great potential in reducing the incidence of hypothermia and reducing the incidence of postoperative complications. In this study, we compared patients who did not implement multi-mode nursing insulation program (MNIP) with those who implemented MNIP, observing and comparing clinical outcomes, and complications in both groups, with the aim of developing an optimal management plan for the preoperative, intraoperative, and postoperative periods, respectively. METHODS We selected 2 periods of 1 year, before (n = 120 patients) and after MINP implementation (n = 120 patients). Data were collected on patient demographics, operative, perioperative details, temperature changes, anesthesia recovery effect, incidence of postoperative wound infection, length of hospital stay and complications. PS analyses were used for dealing with confounding bias in this retrospective observational study. RESULTS After PS matching, the outcomes of 120 well-balanced pairs of patients were compared (No-MNIP vs MNIP). There was no significant difference concerning the satisfaction survey. The results indicated that the MNIP had better insulation effect at 90 min, 120 min, 150 min after anesthesia induction and after surgery. There were 16 cases of complications in the No-MNIP group and 5 cases in the MNIP group postoperative, which have significant statistical difference. CONCLUSION In this study, the incidence of intraoperative hypothermia was effectively reduced by adopting the multi-mode insulation scheme, thus reducing the incidence of incision infection and shortening the length of hospital stay of patients.
Collapse
Affiliation(s)
- Juan Liu
- Changzheng Hospital, Affiliated to Naval Military Medical University, Shanghai, China.
| | - Chunyan Gao
- Changzheng Hospital, Affiliated to Naval Military Medical University, Shanghai, China
| | - Hailong Fu
- Changzheng Hospital, Affiliated to Naval Military Medical University, Shanghai, China
| | - Xiaonan Zhou
- Changzheng Hospital, Affiliated to Naval Military Medical University, Shanghai, China
| | - Li Zhang
- Changzheng Hospital, Affiliated to Naval Military Medical University, Shanghai, China
| | - Xiaomei Tang
- Changzheng Hospital, Affiliated to Naval Military Medical University, Shanghai, China
| | - Yanru Wu
- Changzheng Hospital, Affiliated to Naval Military Medical University, Shanghai, China
| | - Hui Zhu
- Changzheng Hospital, Affiliated to Naval Military Medical University, Shanghai, China
| | - Sisi Yang
- Changzheng Hospital, Affiliated to Naval Military Medical University, Shanghai, China
| | - Yafeng Qu
- Changzheng Hospital, Affiliated to Naval Military Medical University, Shanghai, China
| | - Yajuan Yang
- Changzheng Hospital, Affiliated to Naval Military Medical University, Shanghai, China
| | - Haiqin Yang
- Changzheng Hospital, Affiliated to Naval Military Medical University, Shanghai, China
| |
Collapse
|